Skip to content
Home/Companies/Healthcare/SERB Pharmaceuticals
SP

SERB Pharmaceuticals

Healthcare·Europe·Active·5yr hold

SERB Pharmaceuticals is a healthcare company, headquartered in Europe.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns SERB Pharmaceuticals?

SERB Pharmaceuticals is currently owned by Merieux Equity Partners through Mérieux Participations 3 (2019 vintage), since 2021.

Hand-verified · updated 2026-05-07

Merieux Equity Partners
Investor
Merieux Equity Partners
Mérieux Participations 3 · 2019 · Buyout

Key facts

HQEurope
SectorHealthcare
StatusActive

More from Mérieux Participations 3

Other portfolio companies in the same fund.

Janvier Labs
Active
HealthcareEurope· 2022
Dental Monitoring
Active
HealthcareEurope· 2021
Domus VI
Active
HealthcareEurope· 2021
SWIXX BioPharma
Active
HealthcareEurope· 2021
Elsan
Active
HealthcareEurope· 2020
Plantex
Exited 2025
HealthcareEurope· 2020
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings